Preventing diagnosis delays of lung cancer

Lung cancer is one of the most common and serious types of cancer – sadly, it is often incurable. In common with other cancers, however, prompt diagnosis and early treatment of lung cancer will directly affect survival rates. I recall my first lung cancer misdiagnosis case in which my client’s first question was to ask why was he not offered more sophisticated investigations, over and above an x-ray, which would have achieved an earlier diagnosis which may have saved his life.

On 14 October 2021, healthcare safety organisation, Healthcare Safety Investigation Branch (“HSIB”) published its report detailing its investigations into factors which are contributing to high rates of misdiagnosis for lung cancer in England. HSIB research found that 5 year survival rates for lung cancer in the UK are one of the worst in Europe with two-thirds of patients diagnosed at an advanced stage.  Errors and discrepancies in radiology practice for diagnosing lung cancer have been recognised by HSIB as contributing to the poor survival rates.

Jodi Newton, a specialist medical negligence lawyer at Osbornes Law summarises the report and findings below.

Following the case of a patient who was a non-smoker and whose diagnosis was delayed as a consequence of a failure to identify lung cancer despite three chest x-rays, HSIB opened an investigation. In what they describe as the “reference event”, following the chest x-rays taken over a period of approximately 9 months, the patient was referred for a CT scan which identified lung cancer which appeared to have spread throughout her lungs. The hospital accepted that the findings on the previous x-rays suggested cancer was present but, sadly, this was not identified by the radiologist. The consultant referred the matter as a patient safety investigation and following an initial fact gathering exercise, HSIB authorised a national safety investigation.

The investigation found that:

• Lung cancer in those who have never smoked is increasing.
• That the media have created a strong campaign of messaging about the connection between lung cancer and smoking and as lung cancer has often non-specific symptoms, the adverse impact of this is that GPs have found it more challenging to diagnose.
• While chest x-rays are usually the first test to assess for lung cancer, they are difficult to interpret and about one in five cancers are missed which is likely to falsely reassure the GP.
• The evidence suggested NICE need to amend their safety net advice to healthcare professionals so that it is clearer what should be offered to patients with ongoing unexplained symptoms after a negative chest x-ray.
• A CT scan for screening for high risk lung cancer patients is beneficial. Further research needs to be undertaken as to whether a CT should be the first-line diagnostic test in place of a chest x-ray.

HSIB made 3 safety recommendations to NHS Improvement, NICE, and to NHSX which were as follows:

1. HSIB recommends that NHS England and NHS Improvement works with research partners to explore options for commissioning research to address whether CT scans are clinically more accurate and cost-effective for the diagnosis of lung cancer in symptomatic patients compared to chest X-ray.
2. HSIB recommends that NICE reviews its current safety netting advice to healthcare professionals with respect to the investigation of possible lung cancer. The wording of the advice should be amended to make it clearer what should be offered to patients with ongoing, unexplained symptoms who have had a negative chest X-ray.
3. HSIB recommends that NHSX develops guidance to support independent benchmarking and validation of artificial intelligence algorithms for the identification of lung diseases such as cancer.

That HSIB have recommended strategies to minimise error for diagnosis of lung cancer is a wake-up call to health professionals that this is a serious shortfall and one which can be improved by following HSIB’s advice. At the very least it warrants further research. A chest x-ray has now been highlighted as being an imperfect diagnostic tool and taking steps to minimise this error is likely to save lives from this particularly aggressive form of cancer.

It is also a development which has been well received by radiologists (represented by the Royal College of Radiologists) who support rolling out improved artificial intelligence to minimise diagnostic errors; however,  there is also a recognition that this may not be possible on the NHS due to limited resources including a shortage of staff, equipment, and consultants with the appropriate level of expertise.

If you believe that there has been a failure in care or delay of diagnosis in your case please contact Jodi Newton. She will be able to advise you of the medical negligence claims process, the NHS complaints procedure and whether you can bring a successful claim, on the facts of your case.

Jodi is ranked as a leading medical negligence lawyer in Chambers UK and the Legal 500. She is also an accredited lawyer of AvMA (Action against Medical Accidents). This accreditation means that Jodi has demonstrated a high level of skill and experience in handling medical negligence claims and caring for her clients.

To speak with Jodi call us or fill in the online form below.